Cancer Research Meeting Calendar  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 57, 3305-3313, August 1, 1997]
© 1997 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakamura, T.
Right arrow Articles by Nakamura, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakamura, T.
Right arrow Articles by Nakamura, T.

Induction of Hepatocyte Growth Factor in Fibroblasts by Tumor-derived Factors Affects Invasive Growth of Tumor Cells: In Vitro Analysis of Tumor-Stromal Interactions1

Takao Nakamura, Kunio Matsumoto, Akira Kiritoshi, Yasuo Tano and Toshikazu Nakamura2

Division of Biochemistry, Biomedical Research Center [Ta. N., K. M., To. N.] and Department of Ophthalmology [A. K., Y. T.], Osaka University Medical School, Suita, Osaka 565, Japan

Invasive and metastatic potentials of several types of carcinoma cells are regulated through interactions with host stromal cells, e.g., tumor-stromal interactions. Because hepatocyte growth factor (HGF), a ligand for the c-Met proto-oncogene product, is a mesenchymal- or stromal-derived factor that induces mitogenic, motogenic, and morphogenic responses, we examined the mechanisms involved in tumor-stromal interactions in vitro. The c-Met/HGF receptor was expressed in A431 human epidermoid carcinoma cells, A549 human non-small cell lung cancer cells, HuCC-T1 human cholangiocellular carcinoma cells, and SBC-3 human small cell lung carcinoma cells. HGF stimulated cell growth, scattering, and invasion of these cells. Although these cells did not produce biologically significant levels of HGF, these cells did secrete soluble factors that potently stimulated HGF production in human skin fibroblasts. These carcinoma cell-derived HGF inducers proved to be interleukin-1 (IL-1) in A431 cells, IL-1 plus basic fibroblast growth factor (bFGF) in A549 and HuCC-T1 cells, and bFGF plus platelet-derived growth factor in SBC-3 cells. When these carcinoma cells were cocultured with fibroblasts, HGF levels in the coculture system were much higher than the levels in fibroblasts alone, without cocultured carcinoma cells. Together with the increase in HGF levels, the number of invasive cells increased, but in vitro invasion of carcinoma cells in the coculture system was strongly inhibited by anti-HGF antibodies. Thus, there are mutual interactions between carcinoma cells and fibroblasts: IL-1, bFGF, and platelet-derived growth factor derived from tumor cells play a role in inducing HGF expression in stromal fibroblasts, whereas fibroblast-derived HGF, in turn, leads to invasive growth in carcinoma cells. The mutual interactions, as mediated by HGF and HGF inducers, may play a significant role in the occurrence of invasion and metastasis of carcinoma cells.

1 This study was supported by a research grant for science and cancer research from the Ministry and Education, Science, Sports and Culture of Japan, a research grant for cancer research from the Ministry of Welfare of Japan, and research grants from the Yasuda Medical Foundation, Kudo Foundation, and Tanabe Medical Frontier Foundation.

2 To whom requests for reprints should be addressed. Phone: 81-6-879-3783; Fax: 81-6-879-3789.

Received 12/13/96. Accepted 6/ 2/97.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
K. Sakai, T. Nakamura, K. Matsumoto, and T. Nakamura
Angioinhibitory Action of NK4 Involves Impaired Extracellular Assembly of Fibronectin Mediated by Perlecan-NK4 Association
J. Biol. Chem., August 14, 2009; 284(33): 22491 - 22499.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Wu, Y.-Y. Li, K. Matsushima, T. Baba, and N. Mukaida
CCL3-CCR5 Axis Regulates Intratumoral Accumulation of Leukocytes and Fibroblasts and Promotes Angiogenesis in Murine Lung Metastasis Process
J. Immunol., November 1, 2008; 181(9): 6384 - 6393.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
E. Huet, B. Vallee, D. Szul, F. Verrecchia, S. Mourah, J. V. Jester, T. Hoang-Xuan, S. Menashi, and E. E. Gabison
Extracellular matrix metalloproteinase inducer/CD147 promotes myofibroblast differentiation by inducing {alpha}-smooth muscle actin expression and collagen gel contraction: implications in tissue remodeling
FASEB J, April 1, 2008; 22(4): 1144 - 1154.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
J. Wels, R. N. Kaplan, S. Rafii, and D. Lyden
Migratory neighbors and distant invaders: tumor-associated niche cells
Genes & Dev., March 1, 2008; 22(5): 559 - 574.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C.-Q. Zhu, S. N. Popova, E. R. S. Brown, D. Barsyte-Lovejoy, R. Navab, W. Shih, M. Li, M. Lu, I. Jurisica, L. Z. Penn, et al.
Integrin {alpha}11 regulates IGF2 expression in fibroblasts to enhance tumorigenicity of human non-small-cell lung cancer cells
PNAS, July 10, 2007; 104(28): 11754 - 11759.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y. He, X.-d. Liu, Z.-y. Chen, J. Zhu, Y. Xiong, K. Li, J.-h. Dong, and X. Li
Interaction between Cancer Cells and Stromal Fibroblasts Is Required for Activation of the uPAR-uPA-MMP-2 Cascade in Pancreatic Cancer Metastasis
Clin. Cancer Res., June 1, 2007; 13(11): 3115 - 3124.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Tsujino, I. Seshimo, H. Yamamoto, C. Y. Ngan, K. Ezumi, I. Takemasa, M. Ikeda, M. Sekimoto, N. Matsuura, and M. Monden
Stromal Myofibroblasts Predict Disease Recurrence for Colorectal Cancer
Clin. Cancer Res., April 1, 2007; 13(7): 2082 - 2090.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Ohira, M. Sasaki, K. Harada, Y. Sato, Y. Zen, K. Isse, K. Kozaka, A. Ishikawa, K. Oda, Y. Nimura, et al.
Possible Regulation of Migration of Intrahepatic Cholangiocarcinoma Cells by Interaction of CXCR4 Expressed in Carcinoma Cells with Tumor Necrosis Factor-{alpha} and Stromal-Derived Factor-1 Released in Stroma
Am. J. Pathol., April 1, 2006; 168(4): 1155 - 1168.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Kankuri, D. Cholujova, M. Comajova, A. Vaheri, and J. Bizik
Induction of Hepatocyte Growth Factor/Scatter Factor by Fibroblast Clustering Directly Promotes Tumor Cell Invasiveness
Cancer Res., November 1, 2005; 65(21): 9914 - 9922.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S.-M. Sheen-Chen, Y.-W. Liu, H.-L. Eng, and F.-F. Chou
Serum Levels of Hepatocyte Growth Factor in Patients with Breast Cancer
Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 715 - 717.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Sato, N. Maehara, and M. Goggins
Gene Expression Profiling of Tumor-Stromal Interactions between Pancreatic Cancer Cells and Stromal Fibroblasts
Cancer Res., October 1, 2004; 64(19): 6950 - 6956.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. Mineo, A. Costantino, F. Frasca, L. Sciacca, S. Russo, R. Vigneri, and A. Belfiore
Activation of the Hepatocyte Growth Factor (HGF)-Met System in Papillary Thyroid Cancer: Biological Effects of HGF in Thyroid Cancer Cells Depend on Met Expression Levels
Endocrinology, September 1, 2004; 145(9): 4355 - 4365.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Ohuchida, K. Mizumoto, M. Murakami, L.-W. Qian, N. Sato, E. Nagai, K. Matsumoto, T. Nakamura, and M. Tanaka
Radiation to Stromal Fibroblasts Increases Invasiveness of Pancreatic Cancer Cells through Tumor-Stromal Interactions
Cancer Res., May 1, 2004; 64(9): 3215 - 3222.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
N. A. Bhowmick, A. Chytil, D. Plieth, A. E. Gorska, N. Dumont, S. Shappell, M. K. Washington, E. G. Neilson, and H. L. Moses
TGF-{beta} Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia
Science, February 6, 2004; 303(5659): 848 - 851.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
W. G. Jiang, D. Grimshaw, T. A. Martin, G. Davies, C. Parr, G. Watkins, J. Lane, R. Abounader, J. Laterra, and R. E. Mansel
Reduction of Stromal Fibroblast-induced Mammary Tumor Growth, by Retroviral Ribozyme Transgenes to Hepatocyte Growth Factor/Scatter Factor and its Receptor, c-MET
Clin. Cancer Res., September 15, 2003; 9(11): 4274 - 4281.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Wislez, N. Rabbe, J. Marchal, B. Milleron, B. Crestani, C. Mayaud, M. Antoine, P. Soler, and J. Cadranel
Hepatocyte Growth Factor Production by Neutrophils Infiltrating Bronchioloalveolar Subtype Pulmonary Adenocarcinoma: Role in Tumor Progression and Death
Cancer Res., March 15, 2003; 63(6): 1405 - 1412.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
E. H. Van Aken, O. De Wever, L. Van Hoorde, E. Bruyneel, J.-J. De Laey, and M. M. Mareel
Invasion of Retinal Pigment Epithelial Cells: N-cadherin, Hepatocyte Growth Factor, and Focal Adhesion Kinase
Invest. Ophthalmol. Vis. Sci., February 1, 2003; 44(2): 463 - 472.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P.-C. Chan, C.-C. Liang, K.-C. Yu, M.-C. Chang, W. L. Ho, B.-H. Chen, and H.-C. Chen
Synergistic Effect of Focal Adhesion Kinase Overexpression and Hepatocyte Growth Factor Stimulation on Cell Transformation
J. Biol. Chem., December 20, 2002; 277(52): 50373 - 50379.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Saimura, E. Nagai, K. Mizumoto, N. Maehara, Y. A. Minamishima, M. Katano, K. Matsumoto, T. Nakamura, and M. Tanaka
Tumor Suppression through Angiogenesis Inhibition by SUIT-2 Pancreatic Cancer Cells Genetically Engineered to Secrete NK4
Clin. Cancer Res., October 1, 2002; 8(10): 3243 - 3249.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Yoshida, T. Harada, T. Iwabe, F. Taniguchi, A. Fujii, Y. Sakamoto, N. Yamauchi, G. Shiota, and N. Terakawa
Induction of Hepatocyte Growth Factor in Stromal Cells by Tumor-Derived Basic Fibroblast Growth Factor Enhances Growth and Invasion of Endometrial Cancer
J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2376 - 2383.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Yu and G. Merlino
Constitutive c-Met Signaling through a Nonautocrine Mechanism Promotes Metastasis in a Transgenic Transplantation Model
Cancer Res., May 1, 2002; 62(10): 2951 - 2956.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C.-N. Qian, X. Guo, B. Cao, E. J. Kort, C.-C. Lee, J. Chen, L.-M. Wang, W.-Y. Mai, H.-Q. Min, M.-H. Hong, et al.
Met Protein Expression Level Correlates with Survival in Patients with Late-stage Nasopharyngeal Carcinoma
Cancer Res., January 1, 2002; 62(2): 589 - 596.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Tomioka, N. Maehara, K. Kuba, K. Mizumoto, M. Tanaka, K. Matsumoto, and T. Nakamura
Inhibition of Growth, Invasion, and Metastasis of Human Pancreatic Carcinoma Cells by NK4 in an Orthotopic Mouse Model
Cancer Res., October 1, 2001; 61(20): 7518 - 7524.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Orimo, Y. Tomioka, Y. Shimizu, M. Sato, S. Oigawa, K. Kamata, Y. Nogi, S. Inoue, M. Takahashi, T. Hata, et al.
Cancer-associated Myofibroblasts Possess Various Factors to Promote Endometrial Tumor Progression
Clin. Cancer Res., October 1, 2001; 7(10): 3097 - 3105.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
J. M. Pilewski, T. S. Bumbalo III, A. G. Davis, and J. M. Siegfried
Hepatocyte Growth Factor Promotes Tumor Growth in a Novel In Vivo Model of Human Lung Cancer
Am. J. Respir. Cell Mol. Biol., May 1, 2001; 24(5): 556 - 562.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
M. Tokunou, T. Niki, K. Eguchi, S. Iba, H. Tsuda, T. Yamada, Y. Matsuno, H. Kondo, Y. Saitoh, H. Imamura, et al.
c-MET Expression in Myofibroblasts : Role in Autocrine Activation and Prognostic Significance in Lung Adenocarcinoma
Am. J. Pathol., April 1, 2001; 158(4): 1451 - 1463.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. P. V. Shekhar, J. Werdell, S. J. Santner, R. J. Pauley, and L. Tait
Breast Stroma Plays a Dominant Regulatory Role in Breast Epithelial Growth and Differentiation: Implications for Tumor Development and Progression
Cancer Res., February 1, 2001; 61(4): 1320 - 1326.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
K. Kuba, K. Matsumoto, K. Date, H. Shimura, M. Tanaka, and T. Nakamura
HGF/NK4, a Four-Kringle Antagonist of Hepatocyte Growth Factor, Is an Angiogenesis Inhibitor that Suppresses Tumor Growth and Metastasis in Mice
Cancer Res., December 1, 2000; 60(23): 6737 - 6743.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
N.N.C. Tam, S.S.M. Chung, D.T.W. Lee, and Y.C. Wong
Aberrant expression of hepatocyte growth factor and its receptor, c-Met, during sex hormone-induced prostatic carcinogenesis in the Noble rat
Carcinogenesis, December 1, 2000; 21(12): 2183 - 2191.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Kataoka, R. Hamasuna, H. Itoh, N. Kitamura, and M. Koono
Activation of Hepatocyte Growth Factor/Scatter Factor in Colorectal Carcinoma
Cancer Res., November 1, 2000; 60(21): 6148 - 6159.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
V. J. M. Wielenga, R. van der Voort, T. E. I. Taher, L. Smit, E. A. Beuling, C. van Krimpen, M. Spaargaren, and S. T. Pals
Expression of c-Met and Heparan-Sulfate Proteoglycan Forms of CD44 in Colorectal Cancer
Am. J. Pathol., November 1, 2000; 157(5): 1563 - 1573.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K.-i. Nakashiro, M. Okamoto, Y. Hayashi, and R. Oyasu
Hepatocyte Growth Factor Secreted by Prostate-Derived Stromal Cells Stimulates Growth of Androgen-Independent Human Prostatic Carcinoma Cells
Am. J. Pathol., September 1, 2000; 157(3): 795 - 803.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
R. E. Favoni and A. De Cupis
The Role of Polypeptide Growth Factors in Human Carcinomas: New Targets for a Novel Pharmacological Approach
Pharmacol. Rev., June 1, 2000; 52(2): 179 - 206.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. Moinfar, Y. G. Man, L. Arnould, G. L. Bratthauer, M. Ratschek, and F. A. Tavassoli
Concurrent and Independent Genetic Alterations in the Stromal and Epithelial Cells of Mammary Carcinoma: Implications for Tumorigenesis
Cancer Res., May 1, 2000; 60(9): 2562 - 2566.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
D. Sakkab, M. Lewitzky, G. Posern, U. Schaeper, M. Sachs, W. Birchmeier, and S. M. Feller
Signaling of Hepatocyte Growth Factor/Scatter Factor (HGF) to the Small GTPase Rap1 via the Large Docking Protein Gab1 and the Adapter Protein CRKL
J. Biol. Chem., April 6, 2000; 275(15): 10772 - 10778.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
V. Wallenius, M. Hisaoka, K. Helou, G. Levan, N. Mandahl, J. M. Meis-Kindblom, L.-G. Kindblom, and J.-O. Jansson
Overexpression of the Hepatocyte Growth Factor (HGF) Receptor (Met) and Presence of a Truncated and Activated Intracellular HGF Receptor Fragment in Locally Aggressive/Malignant Human Musculoskeletal Tumors
Am. J. Pathol., March 1, 2000; 156(3): 821 - 829.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
I. C. Anderson, S. E. Mari, R. J. Broderick, B. P. Mari, and M. A. Shipp
The Angiogenic Factor Interleukin 8 Is Induced in Non-Small Cell Lung Cancer/Pulmonary Fibroblast Cocultures
Cancer Res., January 1, 2000; 60(2): 269 - 272.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
A. F. Olumi, G. D. Grossfeld, S. W. Hayward, P. R. Carroll, T. D. Tlsty, and G. R. Cunha
Carcinoma-associated Fibroblasts Direct Tumor Progression of Initiated Human Prostatic Epithelium
Cancer Res., October 1, 1999; 59(19): 5002 - 5011.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Fujisaki, Y. Tanaka, K. Fujii, S. Mine, K. Saito, S. Yamada, U. Yamashita, T. Irimura, and S. Eto
CD44 Stimulation Induces Integrin-mediated Adhesion of Colon Cancer Cell Lines to Endothelial Cells by Up-Regulation of Integrins and c-Met and Activation of Integrins
Cancer Res., September 1, 1999; 59(17): 4427 - 4434.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Nishimura, M. Ushiyama, K. Ohtsuka, M. Nishida, N. Inoue, A. Matsumuro, T. Mineo, and M. Yoshimura
Serum Hepatocyte Growth Factor as a Possible Indicator of Vascular Lesions
J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2475 - 2480.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
T. Tamatani, K. Hattori, A. Iyer, K. Tamatani, and R. Oyasu
Hepatocyte growth factor is an invasion/migration factor of rat urothelial carcinoma cells in vitro
Carcinogenesis, June 1, 1999; 20(6): 957 - 962.
[Abstract] [Full Text] [PDF]


Home page
Arch Otolaryngol Head Neck SurgHome page
S. Yamada, S. Toda, T. Shin, and H. Sugihara
Effects of Stromal Fibroblasts and Fat Cells and an Environmental Factor Air Exposure on Invasion of Laryngeal Carcinoma (HEp-2) Cells in a Collagen Gel Invasion Assay System
Arch Otolaryngol Head Neck Surg, April 1, 1999; 125(4): 424 - 431.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Bhat-Nakshatri, T. R. Newton, R. Goulet Jr., and H. Nakshatri
NF-kappa B activation and interleukin 6 production in fibroblasts by estrogen receptor-negative breast cancer cell-derived interleukin 1alpha
PNAS, June 9, 1998; 95(12): 6971 - 6976.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
H Ohmichi, U Koshimizu, K Matsumoto, and T Nakamura
Hepatocyte growth factor (HGF) acts as a mesenchyme-derived morphogenic factor during fetal lung development
Development, January 4, 1998; 125(7): 1315 - 1324.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1997 by the American Association for Cancer Research.